CasLoc logo
All Cases PTAB Litigations UPC Oppositions

AbbVie Inc. v. Cadila Healthcare Limited

1:12-cv-00065

Overview

Case Number 1:12-cv-00065
Filing Date 2012-01-20
Status Terminated
Termination Date 2013-08-15
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Zydus Pharmaceuticals (USA) Inc. Operating Company

Represented By

1 Attorneys Listed

Francis J. Murphy , Jr.

Murphy, Spadaro & Landon

Tel: +1 (302) 472-8100

Murphy, Spadaro & Landon, 1011 Centre Road

Cadila Healthcare Limited NPE (University / Research)

Represented By

1 Attorneys Listed

Francis J. Murphy , Jr.

Murphy, Spadaro & Landon

Tel: +1 (302) 472-8100

Murphy, Spadaro & Landon, 1011 Centre Road

Plaintiff

AbbVie Respiratory LLC Operating Company

Represented By

2 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Abbott Laboratories NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Abbott Respiratory LLC Operating Company

Represented By

2 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

AbbVie Inc. Operating Company

Represented By

2 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 25 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (25): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6080428
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
Filed: 1995-01-14
Issued: 2000-06-27
Expired (Term Ended)
Expires: 2015-01-14

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(20 total)
Pleading / Complaint

COMPLAINT filed against Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1010214.) - filed by Abbott Respiratory LLC, Abbott Laboratories. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(els) (Entered: 01/23/2012)

Entry #1 • 2012-01-20
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/9/11. Date of Expiration of Patent: 5/27/17.Thirty Month Stay Deadline: 6/9/2014. (els) (Entered: 01/23/2012)

Entry #2 • 2012-01-20
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,080,428;. (els) (Entered: 01/23/2012)

Entry #3 • 2012-01-20
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (els) (Entered: 01/23/2012)

Entry #4 • 2012-01-20
1

Disclosure Statement pursuant to Rule 7.1 filed by Abbott Laboratories, Abbott Respiratory LLC identifying Corporate Parent Kos Pharmaceuticals Inc. for Abbott Respiratory LLC.. (Tigan, Jeremy) (Entered: 02/02/2012)

Entry #5 • 2012-02-02
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc